Kang YK - Search Results

1

Pembrolizumab versus paclitaxel for previously treated advanced gastric or gastroesophageal junction cancer (KEYNOTE-063): A randomized, open-label, phase 3 trial in Asian patients.

Chung HC, Kang YK, Chen Z, Bai Y, Wan Ishak WZ, Shim BY, Park YL, Koo DH, Lu J, Xu J, Chon HJ, Bai LY, Zeng S, Yuan Y, Chen YY, Gu K, Zhong WY, Kuang S, Shih CS, Qin SK. Chung HC, et al. Among authors: kang yk. Cancer. 2022 Mar 1;128(5):995-1003. doi: 10.1002/cncr.34019. Epub 2021 Dec 8. Cancer. 2022. PMID: 34878659 Free PMC article. Clinical Trial.

2

Nephrotoxicity of heptaplatin: a randomized comparison with cisplatin in advanced gastric cancer.

Ahn JH, Kang YK, Kim TW, Bahng H, Chang HM, Kang WC, Kim WK, Lee JS, Park JS. Ahn JH, et al. Among authors: kang wc, kang yk. Cancer Chemother Pharmacol. 2002 Aug;50(2):104-10. doi: 10.1007/s00280-002-0483-x. Epub 2002 Jun 25. Cancer Chemother Pharmacol. 2002. PMID: 12172973 Clinical Trial.

3

Phase II study of paclitaxel and carboplatin in advanced gastric cancer previously treated with 5-fluorouracil and platinum.

Chang HM, Kim TW, Ryu BY, Choi SJ, Park YH, Lee JS, Kim WK, Kang YK. Chang HM, et al. Among authors: kang yk. Jpn J Clin Oncol. 2005 May;35(5):251-5. doi: 10.1093/jjco/hyi077. Epub 2005 May 10. Jpn J Clin Oncol. 2005. PMID: 15886269 Clinical Trial.

4

Combination chemotherapy with capecitabine (X) and Cisplatin (P) as first line treatment in advanced gastric cancer: experience of 223 patients with prognostic factor analysis.

Lee SS, Lee JL, Ryu MH, Chang HM, Kim TW, Kang HJ, Kim WK, Lee JS, Kang YK. Lee SS, et al. Among authors: kang hj, kang yk. Jpn J Clin Oncol. 2007 Jan;37(1):30-7. doi: 10.1093/jjco/hyl134. Jpn J Clin Oncol. 2007. PMID: 17272321

5

Prognostic factors for survival of patients with advanced gastric cancer treated with cisplatin-based chemotherapy.

Kim JG, Ryoo BY, Park YH, Kim BS, Kim TY, Im YH, Kang YK. Kim JG, et al. Among authors: kang yk. Cancer Chemother Pharmacol. 2008 Feb;61(2):301-7. doi: 10.1007/s00280-007-0476-x. Epub 2007 Apr 12. Cancer Chemother Pharmacol. 2008. PMID: 17429626

6

A phase II study of docetaxel as salvage chemotherapy in advanced gastric cancer after failure of fluoropyrimidine and platinum combination chemotherapy.

Lee JL, Ryu MH, Chang HM, Kim TW, Yook JH, Oh ST, Kim BS, Kim M, Chun YJ, Lee JS, Kang YK. Lee JL, et al. Among authors: kang yk. Cancer Chemother Pharmacol. 2008 Apr;61(4):631-7. doi: 10.1007/s00280-007-0516-6. Epub 2007 May 23. Cancer Chemother Pharmacol. 2008. PMID: 17520252 Clinical Trial.

7

Capecitabine in combination with Oxaliplatin (XELOX) as a first-line therapy for advanced gastric cancer.

Park YH, Lee JL, Ryoo BY, Ryu MH, Yang SH, Kim BS, Shin DB, Chang HM, Kim TW, Yuh YJ, Kang YK. Park YH, et al. Among authors: kang yk. Cancer Chemother Pharmacol. 2008 Apr;61(4):623-9. doi: 10.1007/s00280-007-0515-7. Epub 2007 May 24. Cancer Chemother Pharmacol. 2008. PMID: 17522863 Clinical Trial.

8

Phase I/II study of 3-week combination of S-1 and cisplatin chemotherapy for metastatic or recurrent gastric cancer.

Lee JL, Kang HJ, Kang YK, Ryu MH, Chang HM, Kim TW, Sohn HJ, Kim H, Lee JS. Lee JL, et al. Among authors: kang hj, kang yk. Cancer Chemother Pharmacol. 2008 Apr;61(5):837-45. doi: 10.1007/s00280-007-0541-5. Epub 2007 Jun 20. Cancer Chemother Pharmacol. 2008. PMID: 17579864 Clinical Trial.

9

Phase II study of biweekly paclitaxel and cisplatin combination chemotherapy in advanced gastric cancer: Korea Japan Collaborative Study Group Trial.

Kim YH, Yamaguchi K, Bang YJ, Takiuchi H, Kang WK, Sato A, Kang YK, Sakamoto J, Abe C, Sakata Y. Kim YH, et al. Among authors: kang wk, kang yk. Jpn J Clin Oncol. 2007 Jul;37(7):501-8. doi: 10.1093/jjco/hym054. Epub 2007 Aug 2. Jpn J Clin Oncol. 2007. PMID: 17673470 Clinical Trial.

10

A phase II study of irinotecan and docetaxel combination chemotherapy for patients with previously treated metastatic or recurrent advanced gastric cancer.

Sym SJ, Chang HM, Kang HJ, Lee SS, Ryu MH, Lee JL, Kim TW, Yook JH, Oh ST, Kim BS, Kang YK. Sym SJ, et al. Among authors: kang hj, kang yk. Cancer Chemother Pharmacol. 2008 Dec;63(1):1-8. doi: 10.1007/s00280-008-0701-2. Epub 2008 Feb 21. Cancer Chemother Pharmacol. 2008. PMID: 18288477 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

773 results

Search Page